Motor cortical circuitry adaptations in experimental Parkinson's disease

实验性帕金森病中运动皮质电路的适应

• 批准号: 10569032
• 负责人: Hong-Yuan Chu
• 金额: $ 46.62万
• 依托单位: VAN ANDEL RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-15 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10569032
• 关键词: Address; Affect; Age; Aging; Basal Ganglia; Biological Markers; Bradykinesia; Brain; Cells; Clinical Research; Closure by clamp; Corpus striatum structure; Coupled; Data; Development; Disease; Disease Progression; Economic Burden; Electrophysiology (science); Exhibits; Experimental Models; Experimental Parkinsonism; Functional disorder; Gene Expression; Genetic; Heterogeneity; Impairment; Individual; Knowledge; Lesion; Levodopa; Link; Mission; Modeling; Molecular; Motor; Motor Cortex; Motor Skills; Mus; National Institute of Neurological Disorders and Stroke; Nerve Degeneration; Neurodegenerative Disorders; Neuronal Dysfunction; Neurons; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Physiological; Play; Population; Property; Pyramidal Tracts; Research; Role; Secondary to; Structure; Substantia nigra structure; Synapses; Techniques; Time; United States National Institutes of Health; biophysical techniques; cellular pathology; defined contribution; design; dopaminergic neuron; experimental study; functional disability; hippocampal pyramidal neuron; improved; insight; mitopark mouse; motor control; motor deficit; motor disorder; motor symptom; mouse model; neural circuit; novel; optogenetics; patch clamp; pharmacologic; response; socioeconomics; tool

PROJECT SUMMARY Parkinson’s disease (PD) is the second most common neurodegenerative disease of aging and as such it associates with a rapidly growing socioeconomic burden. A hallmark of PD is the loss of dopaminergic (DA) neurons in the substantia nigra, which is causally linked to the debilitating motor symptoms that characterize this disease. However, motor function is not confined to the substantia nigra –other brain structures, like the primary motor cortex (M1) that controls specific sets of motor skills, are affected in PD. Until recently, the abnormal activity of M1 neurons observed in PD was thought to be a direct consequence of an increased basal ganglia inhibition due to the loss of nigral DA neurons. There is now strong evidence indicating that M1 circuitry exhibits adaptive changes in response to loss of DA neurons. Our preliminary data show numerous intrinsic and synaptic adaptations in M1 circuitry. Yet, we lack fundamental understanding of M1 circuitry dysfunction in PD in the context of its neuronal heterogeneity and synaptic complexity. Moreover, compelling evidence shows M1 dysfunction occurs early in PD, but it remains unclear whether it is adaptative or maladaptive as the disease progresses. In the proposed research, we will systematically study how the loss of nigral DA neurons induces adaptative changes in the intrinsic properties of pyramidal neuron subtypes in the layer 5 of M1. We will also determine molecular and ionic mechanisms that associate with these changes (Aim 1). A combination of ex vivo patch-clamp recording with pharmacological and biophysical approaches will be used to address these two questions. Moreover, by combining ex vivo patch-clamp recording with optogenetics, chemogenetics, and connectomics, how the loss of nigral DA neurons alters the connection strength and plasticity of thalamocortical synapses will be determined (Aim 2). Last, the time course of M1 circuitry dysfunction as neurodegeneration occurs will be studied using a mouse model that shows progressive loss of nigral DA neurons and levodopa- responsive motor deficits. In these studies, M1 circuitry dysfunction will be related to the development of motor deficits to determine its role in the onset and progression of motor dysfunction (Aim 3). The information arising from the proposed research will fill the gap in knowledge regarding M1 circuitry dysfunction associated with the loss of nigral DA neurons. This knowledge will aid the identification of novel physiological biomarkers for PD progression and the design of noninvasive approaches targeting M1 for treatment of motor dysfunction in PD.

项目摘要 帕金森病（PD）是第二大常见的衰老性神经退行性疾病， 与快速增长的社会经济负担有关。PD的一个标志是多巴胺能（DA）的丧失 黑质神经元，这是因果关系与衰弱的运动症状，特点 这种疾病。然而，运动功能并不局限于黑质-其他大脑结构，如 控制特定运动技能的初级运动皮层（M1）在PD中受到影响。直至最近缅甸国内 在PD中观察到的M1神经元的异常活动被认为是基础水平增加的直接结果。 由于黑质DA神经元的损失导致的神经节抑制。现在有强有力的证据表明，M1回路 表现出对DA神经元损失的适应性变化。我们的初步数据显示， 以及M1神经回路中的突触适应然而，我们缺乏对M1回路功能障碍的基本了解， 在PD中，神经元异质性和突触复杂性的背景下。此外，令人信服的证据表明， 显示M1功能障碍发生在PD的早期，但目前尚不清楚它是适应性还是适应不良， 疾病进展。 在本研究中，我们将系统地研究黑质DA能神经元的缺失是如何诱导 M1第5层锥体神经元亚型内在特性的适应性变化。我们还将 确定与这些变化相关的分子和离子机制（目标1）。一个组合的前 将使用药理学和生物物理学方法的体内膜片钳记录来解决这些问题 两个问题。此外，通过将离体膜片钳记录与光遗传学、化学遗传学和细胞遗传学相结合， 连接组学，黑质DA神经元的丢失如何改变丘脑皮质的连接强度和可塑性 将确定突触（目标2）。最后，M1回路功能障碍作为神经退行性变的时间过程 将使用小鼠模型进行研究，该模型显示黑质DA神经元和左旋多巴的进行性丧失， 反应性运动缺陷在这些研究中，M1回路功能障碍将与运动发育有关， 缺陷，以确定其在运动功能障碍的发作和进展中的作用（目的3）。 从拟议的研究中产生的信息将填补有关M1电路知识的差距 与黑质DA神经元丢失相关的功能障碍。这些知识将有助于鉴别小说 PD进展的生理生物标志物和针对M1的非侵入性方法的设计， 治疗PD中的运动功能障碍。